Company Monitoring Page for Bluebird-Bio

latest headlines for company on cafepharma

Roche's Spark sues gene therapy rival bluebird for using 'spark' in its marketing campaigns
Fierce Pharma
Thu, 05/20/21 - 11:15 am
Tags:
Roche, Spark Therapeutics, Bluebird Bio, gene therapy, trademark
Bluebird names oncology spinoff, establishes leadership team
Fierce Biotech
Thu, 05/6/21 - 10:58 am
Tags:
Bluebird Bio, spinoffs, cancer, 2seventy bio
Bluebird bio lays off staffers in Europe as Zynteglo rollout hits an early reimbursement snag
Fierce Pharma
Tue, 04/20/21 - 07:38 pm
Tags:
Bluebird Bio, Zynteglo, reimbursement, layoffs, Germany, gene therapy
Bluebird, PsiOxus show oncolytic virus boosts CAR-T in solid tumors
Fierce Biotech
Wed, 04/14/21 - 09:30 am
Tags:
Bluebird Bio, PsiOxus, CAR-T, solid tumors
New CAR-T therapy from Bristol, Bluebird effective but too costly, ICER finds
BioPharma Dive
Tue, 04/6/21 - 11:00 pm
Tags:
Bristol Myers Squibb, Bluebird Bio, ICER, Multiple Myeloma, CAR-T
Bristol Myers, bluebird bio have their BCMA CAR-T nod, but latecomer J&J could have an advantage: analysts
Fierce Pharma
Mon, 03/29/21 - 10:55 pm
Tags:
Bristol Myers Squibb, Bluebird Bio, CAR-T, JNJ, Legend Biotech, Abecma
FDA approves first CAR-T cell therapy for multiple myeloma
BioPharma Dive
Mon, 03/29/21 - 10:25 am
Tags:
Bristol-Myers Squibb, Bluebird Bio, CAR-T, Multiple Myeloma, Abecma, FDA
Bluebird bio CMO quits amid a roller coaster year and upcoming split
Fierce Biotech
Wed, 03/17/21 - 10:54 am
Tags:
Bluebird Bio
Blown off course, Bluebird shares tick up on positive gene therapy readout
Fierce Biotech
Mon, 03/15/21 - 10:54 am
Tags:
Bluebird Bio, cALD, gene therapy, FDA
EMA begins safety review of bluebird gene therapy following AML case in related therapy
Endpoints
Fri, 03/12/21 - 10:32 am
Tags:
Bluebird Bio, Zynteglo, Europe, EMA, AML
Bluebird seeks gene therapy trial restart after cancer scare
Pharmaforum
Wed, 03/10/21 - 11:27 am
Tags:
Bluebird Bio, LentiGlobin, gene therapy, sickle cell disease, AML
Bluebird’s Zynteglo safety snag could spell trouble for other gene therapies: analysts
Fierce Pharma
Thu, 02/18/21 - 09:52 pm
Tags:
gene therapy, Bluebird Bio, Zynteglo, clinical trials
Bluebird stops studies of sickle cell gene therapy after new cancer cases
BioPharma Dive
Tue, 02/16/21 - 11:19 am
Tags:
Bluebird Bio, gene therapy, sickle cell disease, leukemia, clinical trials
Aducanumab tops 2021’s biggest potential launches
EP Vantage
Mon, 01/18/21 - 01:04 pm
Tags:
drug launches, Biogen, Eisai, aducanumab, efgartigimod, Argenx, Evrenzo, FibroGen, Astellas, AstraZeneca, Leqvio, Novartis, UCB Pharma, bimekizumab, Ascendis Pharma, Bluebird Bio, Bristol-Myers Squibb, ide-cel, liso-cel, AXS-05, Axsome Therapeutics, voclosporin, Aurinia
JPM: Bluebird to spin off cancer therapies into new company
Fierce Biotech
Mon, 01/11/21 - 10:26 am
Tags:
Bluebird Bio, spinoffs, oncology, JPMHC 2021, Oncology Newco
10 Biopharma Stories to Look Forward to in 2021
BioSpace
Sun, 01/3/21 - 04:39 pm
Tags:
pandemic, COVID-19, vaccines, Joe Biden, drug pricing, M&A, venture capital, JNJ, Biomarin, Bluebird Bio, TG Therapeutics, Biogen, AstraZeneca
3 FDA Dates Biotech Investors Should Circle in 2021
Motley Fool
Sat, 12/26/20 - 08:27 pm
Tags:
FDA, biotech, Bluebird Bio, ide-cel, Multiple Myeloma, Biogen, aducanumab, Alzheimer's disease, targeted therapeutics, umbralisib, maringal zone lymphoma
Bluebird trumpets long-term data from beta-thalassaemia gene therapy
Pharmaforum
Wed, 12/9/20 - 10:40 am
Tags:
Bluebird Bio, Zinteglo, gene therapy, beta-thalassemia
FDA gene therapy holdups suggest closer scrutiny by agency
BioPharma Dive
Fri, 11/6/20 - 10:07 am
Tags:
FDA, gene therapy, Sarepta Therapeutics, Voyager Therapeutics, Iovance, Bluebird Bio
Can bluebird bio Recover From Another Major Setback?
Motley Fool
Fri, 11/6/20 - 10:00 am
Tags:
Bluebird Bio, bb1111, sickle cell disease

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.